Researchers at Washington University School of Medicine in St. Louis suggest that common stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD), such as Ritalin and Adderall, may work in ways scientists didn’t previously understand. The findings challenge the long-held belief that these drugs primarily improve attention by acting directly on the brain’s attention circuits.
A new large systematic review published this week has raised important questions about the safety and effectiveness of tramadol, a widely prescribed opioid for chronic pain relief. The study, published online ahead of print in BMJ Evidence-Based Medicine, finds that while tramadol does reduce pain compared with placebo, the benefit is small and may not be clinically meaningful for many patients.
In a strategic development that’s set to reshape its vaccine business, Sanofi has announced an agreement to acquire Dynavax Technologies Corporation, a U.S.-based vaccines company known for its marketed adult hepatitis B vaccine and an early-stage shingles vaccine candidate.
A major breakthrough for adults living with rare inherited blood disorders, the U.S. Food and Drug Administration (FDA) has officially approved Agios Pharmaceuticals’ oral drug AQVESME™ (mitapivat) for the treatment of anemia in both alpha- and beta-thalassemia, regardless of whether patients require regular blood transfusions or not.
Biofabri and Bharat Biotech International Limited have signed a technology transfer agreement aimed at improving worldwide access to the promising TB vaccine candidate, MTBVAC.
Ph.D. degree in Life Sciences / Biotechnology / Plant Molecular Biology or having 3 years of research experience after MV.Sc / M.Pharm / ME / M.Tech with good academic record.
A Diploma in Pharmacy / Bachelor of Pharmacy. Must have registered with Pharmacy Council Tamil Nadu and must keep the registration alive by renewing it regularly every year.